Sanofi Off-Patent Brands In Deal Hunter Lupin’s Sights?
This article was originally published in PharmAsia News
Executive Summary
Indian drug maker Lupin is openly scouting for global deals. While it is being seen as a possible bidder for some GSK generic brands, experts say the company may also be involved in examining several other similar transactions.